5,12-Naphthacenedione,10-[[3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)- structure
|
Common Name | 5,12-Naphthacenedione,10-[[3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)- | ||
---|---|---|---|---|
CAS Number | 88254-07-3 | Molecular Weight | 638.61900 | |
Density | 1.59g/cm3 | Boiling Point | 899.2ºC at 760 mmHg | |
Molecular Formula | C32H34N2O12 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 497.6ºC |
Name | 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin |
---|---|
Synonym | More Synonyms |
Density | 1.59g/cm3 |
---|---|
Boiling Point | 899.2ºC at 760 mmHg |
Molecular Formula | C32H34N2O12 |
Molecular Weight | 638.61900 |
Flash Point | 497.6ºC |
Exact Mass | 638.21100 |
PSA | 216.31000 |
LogP | 0.20488 |
Index of Refraction | 1.697 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Precursor 3 | |
---|---|
DownStream 0 |
5,12-Naphthacenedione, 10-[[3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-.α.- L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11- trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- |
MRA-CN |
3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin |
cyanomorpholino-doxorubicin |
3'-Deamino-3'-(3-cyano-4-morpholinyl)adriamycin |